rocuronium bromide

Known as: Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, Bromide 
The bromide salt form of rocuronium, an intermediate-acting quaternary aminosteroid with muscle relaxant property. Rocuronium bromide competitively… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
BACKGROUND Reversal of rocuronium-induced neuromuscular blockade can be accomplished by chemical encapsulation of rocuronium by… (More)
Is this relevant?
2006
2006
BACKGROUND Diagnosis of anaphylaxis from neuromuscular blocking agents (NMBA) is not always straightforward. OBJECTIVES To… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Acetylcholinesterase inhibitors are widely used for the reversal of neuromuscular blocking agents. However… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2004
2004
BACKGROUND Rocuronium bromide, a steroid nondepolarizing muscle relaxant, has a rapid onset and an intermediate duration of… (More)
Is this relevant?
1999
1999
Following administration of 0.6 mg kg-1 rocuronium, the pharmacokinetics and the pharmacodynamics were studied in six obese and… (More)
Is this relevant?
1995
1995
To determine the effect of liver disease on the pharmacokinetics of rocuronium, the authors administered 0.6 mg/kg (twice the… (More)
Is this relevant?
1994
1994
BACKGROUND Rocuronium is a new nondepolarizing neuromuscular blocking agent with a rapid onset but with intermediate duration of… (More)
Is this relevant?
1993
1993
The neuromuscular effects of intravenous rocuronium bromide, 0.6 mg.kg-1 or 0.9 mg.kg-1, were studied in four groups of 10… (More)
Is this relevant?
1993
1993
We have studied the onset and duration of action and pharmacokinetics of rocuronium bromide (Org 9426) during anaesthesia with… (More)
Is this relevant?